A multidisciplinary Delphi consensus in Spain provides recommendations for the early recognition and integrated management of cardiovascular-kidney-metabolic syndrome.
Answers are grounded in this paper and cite their sources.
Guides integrated CKM management in practice now; extends prior siloed guidelines via multidisciplinary consensus.
Objective: We aimed to develop multidisciplinary recommendations for the management of cardiovascular–kidney–metabolic (CKM) syndrome in Spain. Methods: The Delphi method was used. The final questionnaire comprised 61 statements that were assessed using a 9-point Likert scale of agreement, from 1 = fully disagree to 9 = fully agree. A consensus was reached when 80% of answers in all specialties were in the range of 7–9. The overall median was used as a measure of the strength of agreement. Results: A total of 70 (97%) panelists met the selection criteria and completed two rounds, including cardiology (13), endocrinology (12), internal medicine (12), nephrology (14), and primary care (19). Among the 61 statements, a consensus was reached in 54 (89%). The consensus to be highlighted included the following: an excess and/or dysfunction of adipose tissue as the initial driver of CKM syndrome (median 8), CKM syndrome that includes both patients at risk (median 8) and those with existing CVD (median 8), coordination of patient management by the family medicine physician (median 9), the essential role of primary prevention in maintaining CKM health (median 9), the administration of drugs with demonstrated CKM benefit in both early-stage patients (median 9) and those in the advanced stages of the syndrome (median 9), and the importance of lifestyle measures (median 9), with a focus on intensive weight loss (median 9). Conclusions: This Delphi consensus offers multidisciplinary recommendations highlighting the importance of early recognition, integrated management, and the implementation of preventive and therapeutic strategies with established cardiorenal and metabolic benefits.
No takes yet. Share an insight, caveat, or question.
Orozco‐Beltrán et al. (2025) studied Cardiovascular-kidney-metabolic (CKM) syndrome (n=70). Delphi consensus on CKM syndrome management was evaluated on Consensus on statements (defined as 80% agreement in range 7-9). A multidisciplinary Delphi panel of 70 experts reached consensus on 89% of 61 statements regarding the management of cardiovascular-kidney-metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: